| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.98B | -2.2% |
| Cost of Revenue | $1.62B | -3.2% |
| Gross Profit | $364.1M | +2.3% |
| R&D Expense | $23.0M | +8.5% |
| SG&A Expense | $233.8M | -11.4% |
| Operating Income | $6.3M | +101.5% |
| Pre-tax Income | -$78.9M | +83.6% |
| Income Tax | -$30.2M | -212.7% |
| Net Income | -$48.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.3M | -21.5% |
| Accounts Receivable | $162.4M | -8.0% |
| Inventory | $355.1M | +0.6% |
| Current Assets | $658.1M | -7.6% |
| Total Assets | $2.45B | -7.4% |
| Current Liabilities | $274.5M | -2.5% |
| Long-term Debt | $1.11B | -1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $94.8M | -11.1% |
| Capital Expenditures | $55.0M | -16.7% |
| Investing Cash Flow | -$56.7M | -110.4% |
| Financing Cash Flow | -$55.9M | +91.6% |
| Free Cash Flow | $39.8M | -2.0% |
| +84.3% |
| EPS (Basic) | -$0.90 | +84.2% |
| EPS (Diluted) | -$0.90 | +84.2% |
| Total Liabilities |
| $1.59B |
| -6.1% |
| Stockholders' Equity | $858.5M | -9.5% |